Peter Libby
Immunology · 2000–2021
A researcher in the Science corpus: 63 papers; trusts 45 researchers and is trusted by 74 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 368 citations into it; #39 of 2,162 by trust here, #54 by citations
- Surgery — 270 citations into it; #30 of 1,109 by trust here, #14 by citations
- Cardiology and Cardiovascular Medicine — 204 citations into it; #78 of 909 by trust here, #31 by citations
- Epidemiology — 203 citations into it; #24 of 2,156 by trust here, #28 by citations
- Molecular Biology — 195 citations into it; #1,908 of 17,836 by trust here, #1,137 by citations
- Oncology — 152 citations into it; #1,580 of 1,698 by trust here, #426 by citations
- Endocrinology, Diabetes and Metabolism — 117 citations into it; #518 of 624 by trust here, #194 by citations
- Cancer Research — 98 citations into it; #771 of 1,784 by trust here, #680 by citations
Whom Peter Libby trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Peter Libby overall
- I. Tabas
- P. Ridker
- A. Lichtman
- G. Hansson
- K. Bornfeldt
- Byung-Cheol Lee
- V. Z. Rocha
- S. Jackson
- A. Prasad
- G. Geovanini
Papers from Peter Libby's perspective
Ordered by how strongly the researchers Peter Libby trusts endorse each paper. Same corpus, a different order for every researcher.
- Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. (Arteriosclerosis, Thrombosis and Vascular Biology)
- Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study (Circulation)
- Intravascular ultrasound: novel pathophysiological insights and current clinical applications. (Circulation)
- Endothelin Antagonism and Interleukin-6 Inhibition Attenuate the Proatherogenic Effects of C-Reactive Protein (Circulation)
- C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. (New England Journal of Medicine)
- The immune response in atherosclerosis: a double-edged sword (Nature reviews. Immunology)
- Task Force on Sudden Cardiac Death of the European Society of Cardiology. (European Heart Journal)
- Quantification of Macrophage Content in Atherosclerotic Plaques by Optical Coherence Tomography (Circulation)
- The thin-cap fibroatheroma: a type of vulnerable plaque: The major precursor lesion to acute coronary syndromes (Current Opinion in Cardiology)
- Healed Plaque Ruptures and Sudden Coronary Death: Evidence That Subclinical Rupture Has a Role in Plaque Progression (Circulation)
Their papers
- Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites (2009) — 2,240 citations
- The immune response in atherosclerosis: a double-edged sword (2006) — 2,374 citations
- History of Discovery: Inflammation in Atherosclerosis (2012) — 8,757 citations
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease (2017) — 7,832 citations
- Therapeutic siRNA silencing in inflammatory monocytes (2011) — 835 citations
- Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. (2017) — 983 citations
- Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis (2002) — 1,085 citations
- Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). (2011) — 833 citations
- Inflammation in Atherosclerosis: From Pathophysiology to Practice (2009) — 2,213 citations
- A guiding map for inflammation (2017) — 661 citations
- Inflammatory mechanisms: the molecular basis of inflammation and disease. (2007) — 734 citations
- Low-Dose Methotrexate for the Prevention of Atherosclerotic Events (2018) — 1,101 citations
- Cutting Edge: Heat Shock Protein (HSP) 60 Activates the Innate Immune Response: CD14 Is an Essential Receptor for HSP60 Activation of Mononuclear Cells1 (2000) — 608 citations
- Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. (2017) — 783 citations
- Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans (2013) — 657 citations
- Targeting inflammation in atherosclerosis — from experimental insights to the clinic (2021) — 860 citations
- Interleukins in cancer: from biology to therapy (2021) — 665 citations
- The changing landscape of atherosclerosis (2021) — 2,282 citations
- COVID-19 is, in the end, an endothelial disease (2020) — 859 citations
- Atherosclerosis (2019) — 2,081 citations